EVAX
Price:
$3.64
Market Cap:
$22.99M
Evaxion Biotech A/S is a clinical-stage biotechnology firm dedicated to creating artificial intelligence-driven immunotherapies. Its innovative pipeline targets cancers, bacterial infections, and viral diseases. The company's oncology portfolio features several promising candidates: EVX-01, a leading cancer immunotherapy currently in Phase IIb clinical trials for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy undergoing Phase IIa trials for adjuvant melanoma; and EVX-03, another DNA-based immunotherapy in development for a range of cancers. Beyond oncology, Evaxion is advancing three pre-clinical vaccine candidates—EVX-B1, EVX-B2, and EVX-V1—aimed at combating various bacteria...[Read more]
Industry
Biotechnology
IPO Date
2021-02-05
Stock Exchange
NASDAQ
Ticker
EVAX
According to Evaxion Biotech A/S’s latest financial reports and current stock price. The company's current PE Ratio is -3.64. This represents a change of 335.44% compared to the average of -0.84 of the last 4 quarters.
The mean historical PE Ratio of Evaxion Biotech A/S over the last ten years is -9.58. The current -3.64 PE Ratio has changed 3.70% with respect to the historical average. Over the past ten years (40 quarters), EVAX's PE Ratio was at its highest in in the March 2024 quarter at 3.94. The PE Ratio was at its lowest in in the March 2020 quarter at -19.15.
Average
-9.58
Median
-3.97
Minimum
-42.88
Maximum
0
Discovering the peaks and valleys of Evaxion Biotech A/S PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 823.47%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -42.88
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -3.97 | 823.47% |
| 2024 | -0.43 | -59.44% |
| 2023 | -1.06 | -53.23% |
| 2022 | -2.26 | -48.44% |
| 2021 | -4.39 | -67.08% |
| 2020 | -13.33 | -25.47% |
| 2019 | -17.89 | -58.28% |
| 2018 | -42.88 | -Infinity% |
The current PE Ratio of Evaxion Biotech A/S (EVAX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.82
5-year avg
-2.42
10-year avg
-9.58
Evaxion Biotech A/S’s PE Ratio is less than Reviva Pharmaceuticals Holdings, Inc. (-0.29), less than Mural Oncology plc (-0.30), less than Annovis Bio, Inc. (-1.21), less than PolyPid Ltd. (-3.01), less than Generation Bio Co. (-0.57), less than BioAtla, Inc. (-0.11), greater than Veru Inc. (-4.61), greater than SAB Biotherapeutics, Inc. (-447.63), less than Celularity Inc. (-0.20), less than BioXcel Therapeutics, Inc. (-0.18),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.29 | $2.33M | |
| -0.30 | $35.38M | |
| -1.21 | $35.02M | |
| -3.01 | $47.08M | |
| -0.57 | $35.98M | |
| -0.11 | $4.87M | |
| -4.61 | $48.15M | |
| -447.63 | $31.83M | |
| -0.20 | $17.15M | |
| -0.18 | $35.20M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Evaxion Biotech A/S using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Evaxion Biotech A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Evaxion Biotech A/S's PE Ratio?
How is the PE Ratio calculated for Evaxion Biotech A/S (EVAX)?
What is the highest PE Ratio for Evaxion Biotech A/S (EVAX)?
What is the 3-year average PE Ratio for Evaxion Biotech A/S (EVAX)?
What is the 5-year average PE Ratio for Evaxion Biotech A/S (EVAX)?
How does the current PE Ratio for Evaxion Biotech A/S (EVAX) compare to its historical average?